Skip to main content
logo
Noile-Immune Biotech Inc. (TYO:4893)
Japan flag Japan · Delayed Price · Currency is JPY
140.00
+1.00 (0.72%)
Aug 6, 2026, 1:23 PM JST

Noile-Immune Biotech Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
357316625100
Revenue Growth
-57.14%-28.57%-97.78%-49.44%525.00%3.09%
Gross Profit
-49-47-6127461878
Operating Income
-758-797-1,069-776-106-766
Net Income
-706-793-964-1,130-386-795
Earnings Per Share
-16.30-18.31-22.26-27.25-9.85-20.75
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
3,7433,9184,6705,5554,5204,140
Net Cash Growth
-16.17%-16.10%-15.93%22.90%9.18%62.48%
Net Cash Per Share
86.4490.48107.86133.96115.40108.06
Cash & Investments
3,7433,9184,6705,5554,5204,140

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--752-887-873--
Free Cash Flow
--752-887-873--
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---86.71%98.88%78.00%
Operating Margin
-25266.67%-15940.00%-15271.43%-245.57%-16.96%-766.00%
Pretax Margin
-23466.67%-15820.00%-13742.86%-356.96%-61.44%-793.00%
Profit Margin
-23533.33%-15860.00%-13771.43%-357.60%-61.76%-795.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2010.831151.831051.6129.03--